Manifestaciones torácicas y dermatológicas de las enfermedades sistémicas: claves para el radiólogo general
DOI:
https://doi.org/10.53903/01212095.4Palabras clave:
Tomografía computarizada multidetector, Enfermedades pulmonares intersticiales, Enfermedades del tejido conjuntivo, Enfermedades de la pielResumen
Hay una gran cantidad de enfermedades con manifestaciones en tórax y en piel. Dentro de ellas es muy importante la identificación de patrones radiológicos en tomografía computarizada multidetector (TCMD) y su correlación con la clínica, con énfasis en las manifestaciones cutáneas. En este artículo se hace una revisión de las principales entidades infecciosas, inflamatorias, enfermedades de tejido conjuntivo, enfermedades hereditarias y adquiridas. Se brinda información sobre las presentaciones radiológicas más frecuentes en el tórax, como la enfermedad intersticial pulmonar en la que predominan los patrones NINE, NIU y NO, cuya frecuencia varía según la enfermedad y que, a su vez, son diferentes de los patrones radiológicos en TCMD. Se destaca su importancia en pacientes con patologías dermatológicas. Se plantean hallazgos dermatológicos y radiológicos claves para sospechar el diagnóstico de estas patologías, lo que permite al radiólogo entregar una mayor información para definir el tratamiento y seguimiento de dichos pacientes.
Descargas
Referencias bibliográficas
Aluja-Jaramillo F, Acosta L Gutiérrez FR. Neumonitis por hipersensibilidad y en- fermedades del tejido conjuntivo. En: Criales Cortes JL y Gutiérrez FR. Avances en diagnóstico por imágenes: Tórax 2. 2 ed. Buenos Aires: Ediciones Journal; 2019. pp 29-43.
Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44-e68. doi:10.1164/ rccm.201807-1255ST
Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19(2):121-7.
De Lauretis A, Veeraraghavan S, Renzoni E. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis. 2011;8(1):53- 82. https://doi.org/10.1177/1479972310393758
Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44(10):1282-6. https://doi.org/10.1093/rheumatology/keh723
Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004,232:81-91. https://doi.org/10.1148/radiol.2321030174
Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213. https://doi.org/10.1186/ar3097
Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary mani- festations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632-8. https://doi.org/10.1164/rccm.200403-417OC
Kanne JP, Yandow DR, Haemel AK, Mayer CA. Beyond skin deep: Thoracic manifestations of systemic disorders affecting the skin. Radiographics 2011;31(6):1651-68. https://doi.org/10.1148/rg.316115516
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-73. https://doi.org/10.1001/archinternmed.2008.603
Dodd, JD, Souza C, Müller NL. High-Resolution MDCT of pulmonary septic em- bolism: Evaluation of the feeding vessel sign. Am J Roentgenol. 2006;187(3):623-9. https://doi.org/10.2214/AJR.05.0681
Servy A, Valeyrie-Allanore L, Alla F, Lechiche K, Nazeyrollas P, Chidiac C, et al. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol. 2014;150:494-500. https://doi.org/10.1001/jamadermatol.2013.8727
Evangelista A. Echocardiography in infective endocarditis. Heart. 2004;90(6):614-7. https://doi.org/10.1136/hrt.2003.029868
Depasquale R, Kumar N, Lalam RK, Tins BJ, Tyrrell PNM, Singh J, Cassar-Pullicino VN. SAPHO: What radiologists should know. Clin Radiol. 2012;67(3):195-206. https://doi.org/10.1016/j.crad.2011.08.014
Lew PP, Ngai SS, Hamidi R, Cho JK, Birnbaum RA, Peng DH, Varma RK. Ima- ging of disorders affecting the bone and skin. RadioGraphics. 2014;34(1):197-216. https://doi.org/10.1148/rg.341125112
Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET/CT of arthritis in rheumatic diseases: A pictorial review. RadioGraphics. 2020;40(1):223-40. https://doi.org/10.1148/rg.2020190047
Fernández-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol. 2007;25(3):276-87. https://doi.org/10.1016/j.clindermatol.2007.03.004
Aluja-Jaramillo F, Quiasúa-Mejía DC, Martínez-Ordúz HM, González-Ardila C. Nail unit ultrasound: a complete guide of the nail diseases. J Ultrasound. 2017;20(3):181- 92. https://doi.org/10.1007/s40477-017-0253-6
Siltzbach LE. Sarcoidosis: Clinical features and management. Med Clin North Am. 1967;51(2):483-502. https://doi.org/10.1016/S0025-7125(16)33069-3
Nakatsu M, Hatabu H, Morikawa K, Uematsu H, Ohno Y, Nishimura K, et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: "sarcoid galaxy" sign. AJR Am J Roentgenol. 2002;178(6):1389-93. https://doi.org/10.2214/ajr.178.6.1781389
Reddy G, Ahuja J. Thoracic sarcoidosis: Imaging patterns. Sem Roentgenol. 2018:54(1):59-65. https://doi.org/10.1053/j.ro.2018.12.008
Aluja-Jaramillo F, Gutiérrez FR, Rossi S, Bhalla S. Nonneoplastic tracheal abnorma- lities on CT. CDR. 2020;43(13):1-8. https://doi.org/10.1097/01.CDR.0000668644.62958.46
Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol. 2010;10(3):346-52. https://doi.org/10.1016/j.coph.2010.03.001
Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous manifestations of der- matomyositis: A comprehensive review. Clin Rev. 2017;53(3):337-56. https://doi.org/10.1007/s12016-017-8652-1
Hallowell R, Ascherman D, Danoff S. Pulmonary manifestations of polymyositis/ dermatomyositis. Sem Respir Crit Care Med. 2014;35(2):239-48. https://doi.org/10.1055/s-0034-1371528
Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest. 1987;91(1):118-27. https://doi.org/10.1378/chest.91.1.118
Copobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics 2012;32:33-50. https://doi.org/10.1148/rg.321105058
Denton CP, Khanna D. Systemic sclerosis. The Lancet. 2017;390(10103):1685-99. https://doi.org/10.1016/S0140-6736(17)30933-9
Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol. 2010;37(1):42-53. https://doi.org/10.1111/j.1346-8138.2009.00762.x
Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sjögren's syndrome. Curr Allergy Asthma Rep. 2013;13(4):354-60. https://doi.org/10.1007/s11882-013-0357-9
Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. 2010;19(9):1050-70. https://doi.org/10.1177/0961203310370048
Goh YP, Naidoo P, Ngian GS. Imaging of systemic lupus erythematosus. Part I: CNS, cardiovascular, and thoracic manifestations. Clin Radiol. 2013;68(2):181-91. https://doi.org/10.1016/j.crad.2012.06.110
Kinder BW, Freemer MM, King TE Jr, Lum RF, Nitiham J, Taylor K, et al. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum. 2007;56(8):2679-86. https://doi.org/10.1002/art.22804
Paran D, Fireman E, Elkayam O. Pulmonary disease in systemic lupus erythematosus and the antiphospholipid syndrome. Autoimmun Rev. 2004;3(1):70-5. https://doi.org/10.1016/S1568-9972(03)00090-9
Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus a meta analysis. Lupus. 1997;6(5):467-73. https://doi.org/10.1177/096120339700600510
Hoffbrand BI, Beck ER. "Unexplained" dyspnoea and shrinking lungs in systemic lupus erythematosus. BMJ. 1965;1(5445):1273-7. https://doi.org/10.1136/bmj.1.5445.1273
Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in sys- temic lupus erythematosus. Mayo Clin Proc. 2000;75(5):467-72. https://doi.org/10.4065/75.5.467
Massey H, Darby M, Edey A. Thoracic complications of rheumatoid disease. ClinRadiol. 2013;68(3):293-301. https://doi.org/10.1016/j.crad.2012.07.007
Turesson C, Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extraarticular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003:62(8):722-7. https://doi.org/10.1136/ard.62.8.722
Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular mani- festations of rheumatoid arthritis: An update. Autoimmunity Reviews. 2011;11(2):123-31. https://doi.org/10.1016/j.autrev.2011.09.001
Lora V, Cerroni L, Cota C. Skin manifestations of rheumatoid arthritis. G Ital Dermatol Venereol. 2018;153(2):243-55. https://doi.org/10.23736/S0392-0488.18.05872-8
Lieberman-Maran L, Orzano IM, Passero MA, Lally EV. Bronchiectasis in rheumatoid arthritis: Report of four cases and a review of the literature implications for mana- gement with biologic response modifiers. Sem Arthr Rheumat. 2006;35(6):379-87. https://doi.org/10.1016/j.semarthrit.2006.02.003
Franquet, T. High-resolution CT of lung disease related to collagen vascular disease. Radiol Clin North America. 2001;39(6):1171-87. https://doi.org/10.1016/S0033-8389(05)70337-7
Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: Radiologic and pathologic manifestations. RadioGraphics. 2000;20(5):1245-59. https://doi.org/10.1148/radiographics.20.5.g00se081245
Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38(9):1261-5. https://doi.org/10.1086/383317
British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatment, Thorax. 2005;60(10):800-5. https://doi.org/10.1136/thx.2005.046797
Fortman BJ, Kuszyk BS, Urban BA, Fishman EK. Neurofibromatosis Type 1: A diagnostic mimicker at CT. RadioGraphics. 2001;21(3):601-12. https://doi.org/10.1148/radiographics.21.3.g01ma05601
Boley S, Sloan JL, Pemov A, Stewart DR. A quantitative assessment of the burden and distribution of lisch nodules in adults with neurofibromatosis type 1. Investigative Opthalmology & Visual Science. 2009;50(11):5035. https://doi.org/10.1167/iovs.09-3650
Williams M, Verity CM. Optic nerve gliomas in children with neurofibromatosis. Lancet. 1987;1:1318-9. https://doi.org/10.1016/S0140-6736(87)90572-1
Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. The Lancet. 2008;372(9639):657-68. https://doi.org/10.1016/S0140-6736(08)61279-9
Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Academy Sciences. 1991;615:125-7. https://doi.org/10.1111/j.1749-6632.1991.tb37754.x
Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir. Med. 2002;96:1-6. https://doi.org/10.1053/rmed.2001.1207
Ferrans VJ, Yu ZX, Nelson WK, et al. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J Nippon Med Sch. 2000;67(5):311-29. https://doi.org/10.1272/jnms.67.311
Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 1999;115(4):1041- 52. https://doi.org/10.1378/chest.115.4.1041
Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis. 2006;19(1):14-9. https://doi.org/10.1097/01.qco.0000200295.30285.13
Restrepo CS, Martínez S, Lemos JA, Carrillo JA, Lemos DF, Ojeda P, Koshy P. Imaging manifestations of Kaposi sarcoma. Radiographics. 2006;26(4):1169-85. https://doi.org/10.1148/rg.264055129
Willatt HJ, Moyano NC, Apey RC, Lidid AL. Sarcoma de Kaposi extratorácico: evi- dencias de una enfermedad multisistémica. Rev. chil. radiol. 2010;16(2):80-5. https://doi.org/10.4067/S0717-93082010000200008
Wolff SD, Kuhlman JE, Fishman EK. Thoracic Kaposi sarcoma in AIDS: CT findings. J Comput Assist Tomogr. 1993;17(1):60-2. https://doi.org/10.1097/00004728-199301000-00010
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2020 Revista Colombiana de Radiología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
La Revista Colombiana de Radiología es de acceso abierto y todos sus artículos se encuentran libre y completamente disponibles en línea para todo público sin costo alguno.
Los derechos patrimoniales de autor de los textos y de las imágenes del artículo como han sido transferidos pertenecen a la Asociación Colombiana de Radiología (ACR). Por tanto para su reproducción es necesario solicitar permisos y se debe hacer referencia al artículo de la Revista Colombiana de Radiología en las presentaciones o artículos nuevos donde se incluyan.
